1.40

1.41% -0.02

After Hours: 1.40

60 Degrees Pharmaceuticals Inc (SXTP)

Overview News Price History Why SXTP Down? Discussions Forecast

60 Degrees Pharmaceuticals Inc stock is traded at $1.40, with a volume of 28,069. It is down -1.41% in the last 24 hours and up +3.70% over the past month. 60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

Previous Close:

$1.42

Open:

$1.42

24h Volume:

28,069

Relative Volume:

0.05

Market Cap:

$5.75M

Revenue:

$502.40K

Net Income/Loss:

$-7.91M

P/E Ratio:

-0.1404

EPS:

-9.972

Net Cash Flow:

$-4.32M

1W Performance:

-0.71%

1M Performance:

+3.70%

6M Performance:

-24.73%

1Y Performance:

-79.41%

1-Day Range:

$1.37

$1.42

1-Week Range:

$1.3301

$1.45

52-Week Range:

$1.215

$12.45

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name

60 Degrees Pharmaceuticals Inc

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

202-327-5422

Address

1025 CONNECTICUT AVENUE NW, WASHINGTON

Employee

Twitter

Next Earnings Date

2025-08-15

Latest SEC Filings

SXTP's Discussions on Twitter

Compare SXTP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SXTP 60 Degrees Pharmaceuticals Inc	1.40	5.87M	502.40K	-7.91M	-4.32M	-9.972
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

60 Degrees Pharmaceuticals Inc (SXTP)

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Compare SXTP with other stocks

60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News

Identifying reversal signals in 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Analyst Calls & Safe Entry Point Alerts - Newser

Will 60 Degrees Pharmaceuticals Inc. price bounce be sustainablePortfolio Performance Report & Verified Chart Pattern Signals - Newser

What high frequency data says about 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Analyst Calls & Free Daily Entry Point Trade Alerts - Newser

Using Python tools to backtest 60 Degrees Pharmaceuticals Inc. Equity Warrant strategiesPortfolio Performance Report & Long-Term Investment Growth Plans - Newser

Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock poised for growthVolume Spike & AI Driven Stock Reports - Newser

How to manage a losing position in 60 Degrees Pharmaceuticals Inc.Weekly Risk Report & Weekly Top Gainers Trade List - Newser

Is 60 Degrees Pharmaceuticals Inc. trending in predictive chart modelsJobs Report & Growth Oriented Trading Recommendations - Newser

Chart based analysis of 60 Degrees Pharmaceuticals Inc. trendsJuly 2025 Recap & AI Powered Market Trend Analysis - Newser

How to build a custom watchlist for 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Decliners & Smart Investment Allocation Insights - Newser

Can machine learning forecast 60 Degrees Pharmaceuticals Inc. recoveryJuly 2025 Momentum & Technical Pattern Based Signals - Newser

How institutional ownership impacts 60 Degrees Pharmaceuticals Inc. Equity Warrant stockPortfolio Update Summary & Free Weekly Watchlist of Top Performers - Newser

Published on: 2025-09-12 00:52:05 - Newser

Should you wait for a breakout in 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Retail & Risk Controlled Stock Pick Alerts - Newser

Is 60 Degrees Pharmaceuticals Inc. meeting your algorithmic filter criteriaWeekly Trend Report & Verified Technical Trade Signals - Newser

Real time breakdown of 60 Degrees Pharmaceuticals Inc. stock performancePortfolio Growth Summary & High Accuracy Swing Entry Alerts - Newser

Applying chart zones and confluence areas to 60 Degrees Pharmaceuticals Inc.Portfolio Update Report & Expert Curated Trade Ideas - Newser

Risk adjusted return profile for 60 Degrees Pharmaceuticals Inc. Equity Warrant analyzedWeekly Trade Report & AI Enhanced Market Trend Forecasts - Newser

Will 60 Degrees Pharmaceuticals Inc. Equity Warrant continue its uptrendRate Cut & Low Drawdown Trading Techniques - Newser

What technical models suggest about 60 Degrees Pharmaceuticals Inc.’s comebackBond Market & Safe Entry Point Alerts - Newser

Applying chart zones and confluence areas to 60 Degrees Pharmaceuticals Inc. Equity WarrantSell Signal & Safe Entry Momentum Tips - Newser

Quantitative breakdown of 60 Degrees Pharmaceuticals Inc. Equity Warrant recent movePortfolio Value Report & Low Drawdown Momentum Ideas - Newser

Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock recover after recent dropJuly 2025 Reactions & AI Powered Market Entry Ideas - Newser

Using data filters to optimize entry into 60 Degrees Pharmaceuticals Inc.Portfolio Gains Report & Low Risk High Win Rate Stock Picks - Newser

Order flow analysis tools used on 60 Degrees Pharmaceuticals Inc. Equity Warrant - Newser

Combining machine learning predictions for 60 Degrees Pharmaceuticals Inc. Equity WarrantWeekly Risk Summary & Weekly Setup with High ROI Potential - Newser

Using Bollinger Bands to evaluate 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser

What the charts say about 60 Degrees Pharmaceuticals Inc. todayGap Down & Entry and Exit Point Strategies - Newser

What Fibonacci levels say about 60 Degrees Pharmaceuticals Inc. reboundPortfolio Value Report & Risk Controlled Daily Trade Plans - Newser

Measuring 60 Degrees Pharmaceuticals Inc. Equity Warrant’s beta against major indicesMarket Activity Recap & Free Daily Entry Point Trade Alerts - Newser

Using Ichimoku Cloud for 60 Degrees Pharmaceuticals Inc. Equity Warrant technicalsJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - Newser

What are analysts’ price targets for 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Year in Review & Growth Focused Entry Reports - Lancaster City Council

60 Degrees Pharmaceuticals Highlights ARAKODA Growth Potential - TipRanks

How does 60 Degrees Pharmaceuticals Inc. score in quality rankingsEarnings Growth Report & Weekly Setup with ROI Potential - Lancaster City Council

Building trade automation scripts for 60 Degrees Pharmaceuticals Inc. Equity WarrantGap Up & Weekly Momentum Stock Picks - Newser

60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to SXTP